The difference in plaque production between the TgF344-AD and the APP + PS1 rats could be due to the fact that the PS1 transgene in the TgF344-AD had Δ exon 9 mutation, as opposed to the L166P mutation form of the PS1 transgene that was used in these APP + PS1 rats. The gene discussed is APP; the disease is Alzheimer disease.